188 related articles for article (PubMed ID: 35276384)
1. Therapeutic effects of oral fluralaner in pet rabbits with severe sarcoptic mange (Sarcoptes scabiei).
Singh SK; Jaiswal AK; Kumari S; Gaur RS; Sharma P; Khushboo R; Jaiswal M
Vet Parasitol; 2022 Apr; 304():109693. PubMed ID: 35276384
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Fluralaner in the Treatment of Sarcoptic Mange (Sarcoptes scabiei) in 12 Pet Rabbits.
d'Ovidio D; Santoro D
Top Companion Anim Med; 2021 Jun; 43():100528. PubMed ID: 33548547
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of fluralaner administered either orally or topically for the treatment of naturally acquired Sarcoptes scabiei var. canis infestation in dogs.
Taenzler J; Liebenberg J; Roepke RK; Frénais R; Heckeroth AR
Parasit Vectors; 2016 Jul; 9(1):392. PubMed ID: 27387742
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of orally and topically administered fluralaner (Bravecto
Chiummo R; Petersen I; Plehn C; Zschiesche E; Roepke R; Thomas E
Parasit Vectors; 2020 Oct; 13(1):524. PubMed ID: 33069261
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an ELISA using recombinant Ssλ20ΔB3 antigen for the serological diagnosis of Sarcoptes scabiei infestation in domestic and wild rabbits.
Casais R; Millán J; Rosell JM; Dalton KP; Prieto JM
Vet Parasitol; 2015 Dec; 214(3-4):315-21. PubMed ID: 26276579
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a chewable tablet containing sarolaner, moxidectin, and pyrantel (Simparica Trio
Becskei C; Liebenberg J; Fernandes T; Borowski S; D'Hanis L; Mahabir SP
Parasit Vectors; 2023 Nov; 16(1):441. PubMed ID: 38012719
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a spot-on combination of fluralaner plus moxidectin against naturally acquired Sarcoptes scabiei infestation in 10 pet rabbits: Retrospective case series.
d'Ovidio D; Santoro D
Vet Dermatol; 2023 Feb; 34(1):3-6. PubMed ID: 36062517
[TBL] [Abstract][Full Text] [Related]
8. Clinical efficacy of orally administered fluralaner for treatment of scabies in six free-ranging raccoon dogs (Nyctereutes procyonoides).
Hyun JE; Jang HK; Hwang CY; Yeon SC
Vet Dermatol; 2019 Jun; 30(3):267-e81. PubMed ID: 30895701
[TBL] [Abstract][Full Text] [Related]
9. Fluralaner as a novel treatment for sarcoptic mange in the bare-nosed wombat (Vombatus ursinus): safety, pharmacokinetics, efficacy and practicable use.
Wilkinson V; Takano K; Nichols D; Martin A; Holme R; Phalen D; Mounsey K; Charleston M; Kreiss A; Pye R; Browne E; Næsborg-Nielsen C; Richards SA; Carver S
Parasit Vectors; 2021 Jan; 14(1):18. PubMed ID: 33407820
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of fluralaner in 17 dogs with sarcoptic mange.
Romero C; Heredia R; Pineda J; Serrano JA; Mendoza GD; Trápala P; Cordero AM
Vet Dermatol; 2016 Oct; 27(5):353-e88. PubMed ID: 27511592
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the scabicidal effect of a single dose of fluralaner in a rabbit model of crusted scabies.
Sharaf MS; Othman AA; Abd El Ghaffar AE; Ali DM; Eid MM
Parasitol Res; 2023 Nov; 122(11):2477-2490. PubMed ID: 37656230
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the in vitro acaricidal activity of Bravecto
Takano K; Carver S; Vermaak Y; Fischer K; Harvey RJ; Mounsey KE
Parasit Vectors; 2024 Apr; 17(1):194. PubMed ID: 38664829
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife.
Takano K; de Hayr L; Carver S; Harvey RJ; Mounsey KE
Int J Parasitol Drugs Drug Resist; 2023 Apr; 21():97-113. PubMed ID: 36906936
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of a novel oral isoxazoline, sarolaner (Simparica™), for the treatment of sarcoptic mange in dogs.
Becskei C; De Bock F; Illambas J; Cherni JA; Fourie JJ; Lane M; Mahabir SP; Six RH
Vet Parasitol; 2016 May; 222():56-61. PubMed ID: 26928658
[TBL] [Abstract][Full Text] [Related]
15. Effective treatment of sarcoptic mange in an alpaca (Vicugna pacos) using fluralaner: a case report.
Sala G; Gazzonis AL; Pravettoni D; Cafiso A; Grilli G; Ferrulli V; Boccardo A; Di Cesare F; Pavesi LF; Zanzani S
Vet Res Commun; 2024 Jun; 48(3):1837-1843. PubMed ID: 38280082
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary experimental infestation of rabbits (Oryctolagus cuniculus) with Sarcoptes scabiei from a wild rabbit: factors determining resistance to reinfestation.
Casais R; Dalton KP; Millán J; Balseiro A; Oleaga A; Solano P; Goyache F; Prieto JM; Parra F
Vet Parasitol; 2014 Jun; 203(1-2):173-83. PubMed ID: 24690250
[TBL] [Abstract][Full Text] [Related]
17. Silver and gold nanoparticles as a novel approach to fight Sarcoptic mange in rabbits.
Hassanen EI; Morsy EA; Abuowarda M; Ibrahim MA; Shaalan M
Sci Rep; 2024 May; 14(1):10618. PubMed ID: 38724594
[TBL] [Abstract][Full Text] [Related]
18. Comparative diagnostics reveals PCR assays on skin scrapings is the most reliable method to detect Sarcoptes scabiei infestations.
Fraser TA; Martin A; Polkinghorne A; Carver S
Vet Parasitol; 2018 Feb; 251():119-124. PubMed ID: 29426467
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of host resistance to Sarcoptes scabiei var. cuniculi in two different rabbit breeds.
Wei W; Ren Y; Shen N; Song H; Xu J; Hua R; Zhang H; Angel C; Gu X; Kuang L; Xie Y; Peng X; Xie X; Yang G
Parasit Vectors; 2019 Nov; 12(1):530. PubMed ID: 31703721
[TBL] [Abstract][Full Text] [Related]
20. The most effective systemic treatment in dogs with sarcoptic mange: a critically appraised topic.
Dumitrache MO; Cadiergues MC
BMC Vet Res; 2023 Oct; 19(1):189. PubMed ID: 37798627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
